格林國際控股(02700.HK)擬按"1供1"供股 最多籌9900萬港元
格隆匯 9 月 25日丨格林國際控股(02700.HK)公佈,公司建議透過按每股供股股份認購價0.060元發行最多16.50億股供股股份,藉以籌集所得款項總額最多約9900萬港元(扣除開支前),基準為於記錄日期每持有1股現有股份獲發1股供股股份。
假設供股獲悉數接納,其所得款項總額及所得款項淨額預計分別約為9900萬港元及9590萬港元。認購價較股份於最後交易日收市價折讓約17.81%。
公司擬按下列優先順序應用有關所得款項淨額:(i)首1500萬港元用作集團企業開支及管理開支(包括薪金、租金、專業費用及對集團持牌法團的注資);及(ii)剩餘所得款項淨額用於集團醫院業務的潛在收購事項、擴充及設備購置。倘供股認購不足,公司將優先預留足夠資金滿足其企業開支及管理開支需要以維持其持續經營,並往下調整其收購及擴展預算。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.